Can You Trust Elon Musk As A Partner Or Is He A Competitor? Here’s What GM CEO Mary Barra Says
General Motors Co (NYSE: GM) decided to team up with Tesla Inc (NASDAQ: TSLA) for EV charging, but the two companies are still competing for ma
Artelo Biosciences Announces New Data On ART26.12 Demonstrating Effects In Multiple Models Of Neuropathic Pain At The 33rd Annual International Cannabinoid Research Society Symposium
ART26.12, a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor, Shows Favorable Results in Studies for Chemotherapy-Induced Neuropathy and Diabetic Neuropathy
ART26.12 targeting global neuropathic pain
Ocuphire Presents APX3330 ZETA-1 Clinical Data In Late-Breaker Session At The American Diabetes Association’s Annual Conference
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye
World’s Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees
The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week, which gathered over 12,000 people from the entire psy
Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties And Efficacy Of ART12.11 Compared To Cannabidiol At The 33rd Annual International Cannabinoid Research Society Symposium
ART12.11, a novel and patented cocrystal of CBD reverses the impact of chronic stress on outcomes of anxiety, depression, sociability and cognition
ART12.11 aims to address unmet needs within the global
Actinium Pharma Highlights Six Abstracts Accepted For Oral And Poster Presentation At The SNMMI 2023 Annual Meeting
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today details the six abstracts accepted for oral and poster presentation at the upcoming
NextCure Presents Non-Clinical Data Defining The Mechanism Of NC525 At The 2023 Federation Of Clinical Immunology Societies Annual Meeting
NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today
Knightscope’s Robot Roadshow To Be Featured At Tesla Takeover 2023
Knightscope, Inc. (NASDAQ:KSCP) ("Knightscope" or the "Company"), a leading developer of autonomous security robots and blue light emergency communication systems, today announced that the Robot
Lumos To Highlight New LUM-201 Data And Analysis Presented At ENDO 2023 In Virtual KOL Webinar
Webinar to Review Data Demonstrating
Potential Drug Effect and Durable Response
Webinar to be held Today June 21, 2023 at 11:00 AM Eastern Time
AUSTIN, Texas, June 21, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma,
Ocuphire Announces Late Breaking Presentation On APX3330 ZETA-1 Clinical Data At American Diabetes Association Annual Conference
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of retinal and refractive eye disorders, today announced